Why is there so much disorder in eukaryotic proteins? What is its relationship with condensates? Why can some proteins be saved but others get degraded? After years in the making, we think we have answers and they're all connected. Excited to share a 🧵:
biorxiv.org/content/10.1101/…
There is also an important role for the RGG region, which interacts with the dimerization domains and provides greater valency and alters dynamics. But the IDR of PGL-3 is actually solubilizing and does not form forming multivalent interactions
Piyoosh Sharma from @fried_lab used XL-MS to highlight exactly which residues are involved in forming multivalent interaction networks. Some homotypic crosslinks are NOT consistent with the canonical dimer structure, suggesting "dimerization" domains can oligomerize >2 copies
The basic result is largely conveyed by these fluorescence micrographs. To condense, PGL3 needs D1 and D2. RGG helps; IDR makes it harder. The indefatigable Rimpei Kuroiwa of @Seydouxlab used many more biochem/biophys techniques to support this counterintuitive result.
Disordered regions are not necessary for phase separation, in fact sometimes they inhibit it. The dimerization domains of PGL-3 are multivalent, necessary, and sufficient for LLPS into P-granules. As we show with @Seydouxlab in this @emboreports paper link.springer.com/article/10…
Do you like proteins and beautiful architecture? Join us in Prague for this exciting line-up of speakers in protein science. Kudos to the organizers for putting this together. Registration opens today at pragueproteinspring.cz/
I’m so proud of all 4 of you. At such a challenging time for biomedical science your success and hard work is a reminder to us PIs why we do what we do, and why it’s worth it! @fried_lab will miss you but can’t wait to hear what you discover next ❤️!
This is literally why - in a nutshell - NIGMS moved away from the R01 model in favour of MIRA. enormous labs that work on myriads of loosely related projects are less likely to produce breakthroughs than a group that focuses on a coherent big picture goal.
Ever wondered who the real rockstars of R01s from the past 5 years?
We ranked the most funded PIs in cancer R01s from 2020–2024.
Anyone with persistent effort can (maybe) win one R01. Winning 38–48 of them over 5 years is something else entirely.
R01s flow towards people whose ideas repeatedly translate into durable programs.
Durability means:
• hypotheses that age well
• biology that generalizes
• institutions that trust you with long arcs
• and ideas NIH is willing to underwrite repeatedly
========
Meet the rockstars, their institutions, and an examplary funded research:
Allen Gao (University of California, Davis @ucdavis)
48 R01 awards | $14.6M
Sample Award: 5R01CA271327
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
Xiaoqi Liu (University of Kentucky @universityofky )
46 R01 awards | $20.3M
Sample Award: 5R01CA272483-03
Targeting the PLK1/PDCD4/mTORC2 signaling to treat castration-resistant prostate cancer
Tim Rebbeck (Dana-Farber Cancer Institute @DanaFarber)
43 R01 awards | $10.4M
Sample Award: 5R01CA259200
Genetic and genomic variation in prostate cancer
Shoujiang Gao (University of Pittsburgh School of Medicine @PittTweet)
42 R01 awards | $21.3M
Sample Award: 5R01CA284554
Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy
James Basilion (Case Western Reserve University School of Medicine @cwru)
39 R01 awards | $18.2M
Sample Award: 5R01CA255925
Highly selective targeted theranostics for prostate cancers
Binghui Shen (City of Hope Beckman Research Institute @cityofhope)
39 R01 awards | $16.6M
Sample Award: 5R01CA233664
DNA repair gene mutations and prostate cancer
Daniela Bota (UC Irvine @UCIMedSchool)
39 R01 awards | $10.4M
Sample Award: 5R01CA263806
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
Nan Hao (UC San Diego @UCSDMedSchool)
38 R01 awards | $17.1M
Sample Award: 1R01AG086348
Engineered genetic clocks for control of cellular aging
Zhenghe Wang (Case Western Reserve University School of Medicine @cwru)
38 R01 awards | $16.8M
Sample Award: 4R01CA260629
Role of PTPRT in colon cancer progression and metastasis
Tony Faber (Virginia Commonwealth University School of Medicine)
38 R01 awards | $16.6M
Sample Award: 5R01CA276207
MYCN drives a ferroptotic vulnerability in neuroblastoma
Both chambers of Congress have now passed the FY26 minibus with NIH provisions. The President will sign.
(1) $48.7 billion for NIH
(2) Full IDC recovery
(3) No more multi-year funding
(4) No NIH reorganization, maintaining the current IC structure.
Limited proteolysis-coupled mass spectrometry captures proteome-wide protein structural alterations and biomolecular condensation in living cells: link.springer.com/article/10…
What does this mean for protein misfolding in aging and disease? Stay tuned, we are on it! Funded by @NSF@NIH_CommonFund@SloanFoundation@dreyfusfndn. Huge congrats to April Xia for pushing through confusing results and making this discovery!